ESTIMATE OF BONE BIOMARKER ON OSTEOPOROSIS IN IRAQI POSTMENOPAUSAL WOMEN

Zainab qasim Abd  AlSahib; Muataz Hussein Ali

doi:10.61796/jmgcb.v1i8.886

Authors

Zainab qasim Abd AlSahib
zainab9qasim@gmail.com
Muataz Hussein Ali

Vol. 1 No. 8 (2024): Journal of Medical Genetics and Clinical Biology

Articles

September 4, 2024

Downloads

View Article

Abstract
How to Cite
Metrics
References
License

Background; Osteoporosis (OP) is a chronic and a progressive disease characterized by low bone mass and micro-architectural deterioration of bone tissue, resulting in an increased risk of fracture .Dual-energy X-ray absorptiometry (DXA) is commonly used for diagnosis of osteoporosis. Bone turnover markers have advantages over DXA, as they are cheap, non-invasive and can detect changes in bone turnover rates earlier. Aims of the study: to investigate the significance of bone turnover biochemical markers; serum parathyroid, serum osteopontin and Vitamin D3 in evaluating osteoporosis for postmenopausal Iraqi women with and without history of vertebral fracture, as well as to explore the relationship of these markers with bone mineral density (BMD). Methodology: Forty-four (85) postmenopausal women were included in this study with age range (45-70years). Subjects were divided into three groups: osteoporosis postmenopausal women: (n=45), osteopenia postmenopausal women: (n=24) and healthy postmenopausal women (n=16) (serve as controls). Patients were diagnosed as osteoporosis and controls as normal by measuring bone mineral density (BMD), using dual energy x-ray absorptiometry (DXA). In addition, serum calcium, phosphorous and alkaline phosphatase measured by spectrophotometer. Result; BMD and T-score were significantly lower in osteoporotic postmenopausal group as compared with healthy group (p=0.009) (p=<0.001). Serum ALP levels were elevated significantly in osteoporotic postmenopausal group as compared with healthy group (p=<0.001). Serum Ca levels and serum PO4 levels were elevated significantly in Healthy postmenopausal group as compared with osteoporotic group (p=0.65) (p=0.957). Conclusions: The levels of ALP in serum could be used as a biochemical indicator in the early diagnosis of osteoporosis postmenopausal women.

AlSahib, Z. qasim A. ., & Ali, M. H. (2024). ESTIMATE OF BONE BIOMARKER ON OSTEOPOROSIS IN IRAQI POSTMENOPAUSAL WOMEN. Journal of Medical Genetics and Clinical Biology, 1(8), 325–331. https://doi.org/10.61796/jmgcb.v1i8.886

Download Citation

M. Abdelmohsen, "Comparison of Central and Peripheral Bone Mineral Density Measurements in Postmenopausal Women," Journal of Chiropractic Medicine, vol. 16, no. 3, pp. 199-203, 2017.

C. Alexandre, "Androgens and Bone Metabolism," Joint Bone Spine, vol. 72, no. 3, pp. 202-206, 2005.

N. K. Ali, "Estimation of Some Mineral (Calcium, Phosphorous, Vitamin 25 (OH) D, and Alkaline Phosphatase) in Osteoporosis Patients in Kirkuk City," Journal of Osteoporosis & Physical Activity, vol. 6, no. 2, 2018.

A. M. A. Allah, S. A. El Tarhouny, S. A. Khodeer, and W. A. Shehab-Eldin, "The Value of Osteopontin and Matrix Metalloproteinase-3 in the Assessment of Bone Mineral Density in Postmenopausal Women," Menoufia Medical Journal, vol. 30, no. 4, pp. 1065-1071, 2017.

M. A. Al-Maatouq, M. I. El-Desouki, S. A. Othman, E. H. Mattar, Z. A. Babay, and M. Addar, "Prevalence of Osteoporosis Among Postmenopausal Females With Diabetes Mellitus," Saudi Medical Journal, vol. 25, no. 10, pp. 1423-1427, 2004.

B. I. Al-Nejjar, O. F. Abdulrasheed, and G. A. Al-shamaa, "The Values of Osteopontin and Bone-Specific Alkaline Phosphatase in Diagnosis of Osteoporosis: A Comparative Study," Medical Journal of Babylon, vol. 12, no. 4, pp. 987-998, 2015.

I. C. Chang, T. I. Chiang, K. T. Yeh, H. Lee, and Y. W. Cheng, "Increased Serum Osteopontin is a Risk Factor for Osteoporosis in Menopausal Women," Osteoporosis International, vol. 21, no. 8, pp. 1401-1409, 2010.

P. A. Downey and M. I. Siegel, "Bone Biology and the Clinical Implications for Osteoporosis," Physical Therapy, vol. 86, no. 1, pp. 77-91, 2006.

R. Eastell, "Pathogenesis of Postmenopausal Osteoporosis," in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, M. J. Favus, Ed. Washington, DC: American Society for Bone and Mineral Research, 2003, pp. 314-316.

K. E. Ensrud et al., "Hip and Calcaneal Bone Loss Increase With Advancing Age: Longitudinal Results From the Study of Osteoporotic Fractures," Journal of Bone and Mineral Research, vol. 10, no. 11, pp. 1778-1787, 1995.

H. C. Fantasia, "A Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms of Menopause," Nursing for Women’s Health, vol. 20, no. 5, pp. 511-518, 2016.

G. R. Frank, "Role of Estrogen and Androgen in Pubertal Skeletal Physiology," Medical and Pediatric Oncology, vol. 41, no. 3, pp. 217-221, 2003.

P. Garnero, "Bone Markers in Osteoporosis," Current Osteoporosis Reports, vol. 7, no. 3, pp. 84-90, 2009.

P. Garnero, E. Sornay-Rendu, B. Claustrat, and P. D. Delmas, "Biochemical Markers of Bone Turnover, Endogenous Hormones, and the Risk of Fractures in Postmenopausal Women: The OFELY Study," Journal of Bone and Mineral Research, vol. 15, no. 8, pp. 1526-1536, 2000.

D. Grigorie et al., "High Prevalence of Vitamin D Deficiency in 1048 Romanian Women With Postmenopausal Osteoporosis," Acta Endocrinologica (Bucharest), vol. 4, no. 1, pp. 33-45, 2008.

P. Lips, "Vitamin D Status and Nutrition in Europe and Asia," The Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3-5, pp. 620-625, 2007.

S. L. Hui et al., "Bone Loss at the Femoral Neck in Premenopausal White Women: Effects of Weight Change and Sex-Hormone Levels," The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 4, pp. 1539-1543, 2002.

M. Karimifar et al., "Evaluation of Bone Loss in Diabetic Postmenopausal Women," Journal of Research in Medical Sciences, vol. 17, no. 11, pp. 1033-1038, 2012.

H. Kronenberg, Williams Textbook of Endocrinology, 11th ed. Philadelphia, PA: Elsevier Health Sciences, 2007.

P. Mezquita-Raya et al., "Relation Between Vitamin D Insufficiency, Bone Density, and Bone Metabolism in Healthy Postmenopausal Women," Journal of Bone and Mineral Research, vol. 16, no. 8, pp. 1408-1415, 2001.

R. Nuti et al., "Guidelines for the Management of Osteoporosis and Fragility Fractures," Internal and Emergency Medicine, vol. 14, no. 1, pp. 85-102, 2019.

H. Pham, H. J. Roth, and I. Zahn, "Evaluation of the IDS-iSYS Bone Alkaline Phosphatase (BAP) Assay," Bone, vol. 48, no. 1, pp. S221, 2011.

H. J. Qureshi et al., "Calcium Status in Premenopausal and Postmenopausal Women," Journal of Ayub Medical College Abbottabad, vol. 22, no. 2, pp. 143-145, 2010.

B. L. Riggs et al., "Evidence That Type I Osteoporosis Results From Enhanced Responsiveness of Bone to Estrogen Deficiency," Osteoporosis International, vol. 14, no. 9, pp. 728-733, 2003.

S. Tanaka et al., "Lower Osteocalcin and Osteopontin Contents of the Femoral Head in Hip Fracture Patients Than Osteoarthritis Patients," Osteoporosis International, vol. 22, no. 2, pp. 587-597, 2011.

K. M. Turki, M. H. Al-Osami, and N. S. Mohammed, "Evaluation of Serum Osteocalcin and Osteopontin Levels as Bone Biochemical Markers in Postmenopausal Women," Al-Kindy College Medical Journal, vol. 9, no. 2, pp. 40-44, 2013.

J. Walker, "Osteoporosis: Pathogenesis, Diagnosis and Management," Nursing Standard, vol. 22, no. 17, pp. 48, 2008.

Q. S. Wei et al., "Serum Osteopontin Levels in Relation to Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women," Scandinavian Journal of Clinical and Laboratory Investigation, vol. 76, no. 1, pp. 33-39, 2016.

Journal of Medical Genetics and Clinical Biology

ESTIMATE OF BONE BIOMARKER ON OSTEOPOROSIS IN IRAQI POSTMENOPAUSAL WOMEN

Authors

Downloads

Template

LeftColumnStart